| Identification | Back Directory | [Name]
NXT629 | [CAS]
1454925-59-7 | [Synonyms]
NXT629
Benzenesulfonamide, N-[6-[4-[3-[1-[[4-(1,1-dimethylethyl)phenyl]methyl]-4-ethyl-4,5-dihydro-5-oxo-1H-1,2,4-triazol-3-yl]propyl]phenyl]-3-pyridinyl]- | [Molecular Formula]
C35H39N5O3S | [MOL File]
1454925-59-7.mol | [Molecular Weight]
609.78 |
| Chemical Properties | Back Directory | [Boiling point ]
734.5±70.0 °C(Predicted) | [density ]
1.20±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 125 mg/mL (204.99 mM) | [form ]
Solid | [pka]
7.54±0.40(Predicted) | [color ]
Light yellow to yellow |
| Hazard Information | Back Directory | [Description]
NXT629 is a potent, selective, and competitive PPAR-α antagonist. It has potent anti-tumor activity and inhibits experimental metastasis of cancer cell in animal models. |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|